Resveratrol induces the production of reactive oxygen species, interferes with the cell cycle, and inhibits the cell migration of bladder tumour cells with different TP53 status-Reference-Cited by-同舟云学术

Resveratrol induces the production of reactive oxygen species, interferes with the cell cycle, and inhibits the cell migration of bladder tumour cells with different TP53 status

Published:2022-11-28 Issue: Volume: Page:1-6
ISSN:1478-6419
Container-title:Natural Product Research
language:en
Short-container-title:Natural Product Research

Author:

Almeida Tamires Cunha¹,Melo André Sacramento²,Lima Ana Paula Braga¹^ORCID,Branquinho Renata Tupinambá¹,da Silva Glenda Nicioli¹³^ORCID

Affiliation:

1. Programa de Pós-graduação em Ciências Farmacêuticas (CIPHARMA), Universidade Federal de Ouro Preto, Ouro Preto, Brazil

2. Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Preto, Brazil

3. Programa de Pós-graduação em Ciências Biológicas (CBIOL), Universidade Federal de Ouro Preto, Ouro Preto, Brazil

Funder

Universidade Federal de Ouro Preto

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

CNPq

Publisher

Informa UK Limited

Subject

Organic Chemistry,Plant Science,Biochemistry,Analytical Chemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/14786419.2022.2151007

Reference36 articles.

1. Antiproliferative and toxicogenomic effects of resveratrol in bladder cancer cells with different TP53 status

2. Resveratrol effects in bladder cancer: A mini review

3. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

4. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms

5. Unlocking bladder cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resveratrol: A Review on the Biological Activity and Applications;Applied Sciences;2024-05-25

2. Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent;Pharmaceuticals;2024-01-18

3. Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence;Antioxidants;2023-05-26